Evidence-Based Reviews

Delirium in the hospital: Emphasis on the management of geriatric patients

Author and Disclosure Information

 

References

In controlled trials, atypical antipsychot­ics for delirium showed efficacy compared with haloperidol.52,55 However, there is no research that demonstrates any advantage of one atypical over another.25

In Mr. D’s case, the most important inter­vention for managing delirium caused by NMS is to discontinue all dopamine antag­onists and treat agitation with judicious doses of a benzodiazepine, with supportive care.17 In cases of sudden discontinuation or a dosage decrease of dopamine agonists, these medications should be resumed or optimized to minimize the risk of NMS-associated rhabdomyolysis and subse­quent renal failure.17 Antipsychotics carry an increased risk of stroke and mortality in older patients with established or evolving neurocognitive disorders56,57 and can cause prolongation of the QTc interval.57

Other medications that could be used for delirium include cholinesterase inhibitors58,59 (although larger trials and a systematic review did not support this use60), and 5-HT receptor antagonists,61 such as trazodone. Benzodiazepines, such as lorazepam, are first-line treatment for delirium associated with seizures or withdrawal from alcohol, sedatives, hypnotics, and anxiolytics and for delirium caused by NMS. Be cautious about using benzodiazepines in geriatric patients because of a risk of respiratory depression, falls, sedation, and amnesia.

Geriatric patients with alcoholism and those with malnutrition are prone to thia­mine and vitamin B12 deficiencies, which can induce delirium. Laboratory assessment and consideration of supplementation is recom­mended. Despite high occurrence of delirium in hospitalized older adults with preexisting comorbid neurocognitive disorders, there is no standard care for delirium comorbid with another neurocognitive disorder.62 Clinical practice guidelines for older patients receiv­ing palliative care have been developed63; the goal is to minimize suffering and discomfort in patients in palliative care.64

Post-delirium prophylaxis. Medications for delirium usually can be tapered and discontinued once the episode has resolved and the patient is stable; it is common to discontinue medications when the patient has been symptom-free for 1 week.65 Some patients (eg, with end-stage liver disease, disseminated cancer) are prone to recur­rent or to prolonged or chronic delirium. A period of post-recovery treatment with antipsychotics—even indefinite treatment in some cases—should be considered.

Post-delirium debriefing and aftercare. The psychological complications of delirium are distressing for the patient and his (her) caregivers. Psychiatric complications asso­ciated with delirium, including acute stress disorder—which might predict posttraumatic stress disorder—have been explored; early recognition and treatment may improve long-term outcomes.66 After recovery from acute delirium, cognitive assessment (eg, MMSE67 or Montreal Cognitive Assessment68) is recommended to validate current cognitive status because patients may have persistent decrement in cognitive func­tion compared with pre-delirium condition, even after recovery from the acute episode.

Post-delirium debriefing may help patients who have recovered from a delirium episode. Patients may fear that their brief period of hallucinations might represent the onset of a chronic-relapsing psychotic dis­order. Allow patients to communicate their distress about the delirium episode and give them the opportunity to talk through the experience. Brief them on the possibility that delirium will recur and advise them to seek emergency medical care in case of recur­rence. Advise patients to monitor and main­tain a normal sleep-wake cycle.

Family members can watch for syndro­mal recurrence of delirium. They should be encouraged to discuss their reaction to hav­ing seen their relative in a delirious state.

Health care systems with integrated electronic medical records should list “delirium, resolved” on the patient’s illness profile or problem list and alert the patient’s primary care provider to the delirium his­tory to avoid future exposure to delirium-provocative medications, and to prompt the provider to assume an active role in post-delirium care, including delirium recur­rence surveillance, medication adjustment, risk factor management, and post-recovery cognitive assessment.

Bottom Line
Evaluation of delirium in geriatric patients includes clinical vigilance and screening, differentiating delirium from other neurocognitive disorders, and identifying and treating underlying causes. Perioperative use of antipsychotics may reduce the incidence of delirium, although hospital length of stay generally has not been reduced with prophylaxis. Management interventions include staff education, systematic screening, use of multicomponent interventions, and pharmacologic interventions.

Related Resources
• Downing LJ, Caprio TV, Lyness JM. Geriatric psychiatry review: differential diagnosis and treatment of the 3 D’s - delirium, dementia, and depression. Curr Psychiatry Rep. 2013;15(6):365.
• Brooks PB. Postoperative delirium in elderly patients. Am J Nurs. 2012;112(9):38-49.

Drug Brand Names
Carbidopa/levodopa • Sinemet Midazolam • Versed
Dexmedetomidine • Precedex Olanzapine • Zyprexa
Haloperidol • Haldol Propofol • Diprivan
Lithium • Eskalith, Lithobid Quetiapine • Seroquel
Lorazepam • Ativan Risperidone • Risperdal
Metoclopramide • Reglan Trazodone • Desyrel

Disclosures
The authors report no financial relationships with any company whose products are mentioned in this article or with manufacturers of competing products.

Pages

Recommended Reading

VIDEO: Don’t brush off subjective memory decline
MDedge Psychiatry
VIDEO: Investigative eye amyloid test shines a light on Alzheimer’s pathology
MDedge Psychiatry
Alzheimer’s disease antibody crenezumab doesn’t deliver in phase II trial
MDedge Psychiatry
VIDEO: Consider cognitive function in elderly before surgery
MDedge Psychiatry
Many dementia patients have guns at home
MDedge Psychiatry
VIDEO: In patients with dementia, ask about guns at home
MDedge Psychiatry
VIDEO: Dementia risk spikes in older veterans with sleep disorders, PTSD
MDedge Psychiatry
VIDEO: Lifestyle improvements prevented cognitive decline in at-risk elderly
MDedge Psychiatry
VIDEO: Late-life hypertension may reduce dementia risk
MDedge Psychiatry
How to talk to patients and their family after a diagnosis of mild cognitive impairment
MDedge Psychiatry

Related Articles